Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Banco Santander México $700 million senior notes offering
We advised Banco Santander México on the investment-grade offering
Ryan Specialty $600 million senior secured notes offering
The high-yield notes are due 2032
Live Nation Entertainment $1.1 billion convertible senior notes offering
The 2.875% convertible notes are due 2030
Gruma $800 million senior notes offering
The notes are due 2034 and 2054
IREN $440 million convertible notes offering
We advised IREN on the offering
MoneyLion $1 billion acquisition by Gen Digital
We are advising MoneyLion on the acquisition
Arthur J. Gallagher $13.45 billion AssuredPartners bridge acquisition financing
We advised the lead arrangers and agent on the bridge facility
Amer Sports $1.05 billion follow-on offering
We advised Amer Sports on its SEC-registered offering
Revolution Medicines $750 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
PG&E $2.76 billion common and preferred share offerings
The common stock is, and the preferred stock will be, listed on the NYSE